TALS
Income statement / Annual
Last year (2022), Talaris Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2022, Talaris Therapeutics, Inc.'s net income was -$68.73 M.
See Talaris Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$57.01 M
|
$34.25 M
|
$15.28 M
|
$13.37 M
|
| General & Administrative
Expenses |
$19.47 M
|
$13.26 M
|
$7.41 M
|
$5.01 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$19.47 M
|
$13.26 M
|
$7.41 M
|
$5.01 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$76.48 M |
$47.51 M |
$22.68 M |
$18.38 M |
| Cost And Expenses |
$76.48 M |
$47.51 M |
$22.68 M |
$18.38 M |
| Interest Income |
$900.00 |
$0.00 |
$400.00 |
$200.00 |
| Interest Expense |
$2.58 M |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$2.16 M
|
$623,000.00
|
$447,000.00
|
$379,000.00
|
| EBITDA |
-$74.32 M
|
-$46.88 M
|
-$22.24 M
|
-$18.00 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$2.58 M
|
-$326,000.00
|
-$23,000.00
|
$223,000.00
|
| Income Before Tax |
-$73.89 M |
-$47.83 M |
-$22.71 M |
-$18.16 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$5.17 M |
$326,000.00 |
$23,000.00 |
-$223,000.00 |
| Net Income |
-$68.73 M |
-$48.16 M |
-$22.73 M |
-$17.93 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
| EPS |
-16.66 |
-16.53 |
-34 |
-28.09 |
| EPS Diluted |
-16.66 |
-16.53 |
-34 |
-28.09 |
| Weighted Average Shares
Out |
$4.12 M
|
$2.91 M
|
$668,507.00
|
$638,325.00
|
| Weighted Average Shares
Out Diluted |
$4.12 M
|
$2.91 M
|
$668,507.00
|
$638,325.00
|
| Link |
|
|
|
|
